Introduction

Interstitial lung diseases (ILDs) comprise a heterogeneous group of disorders characterized by varying degrees of inflammation and fibrosis, affecting the lung parenchyma. Despite the diverse etiologies, these disorders share similar clinical, radiological, and histopathological features, making diagnosis and management challenging.

Etiology and Classification

ILDs can be classified based on etiology into idiopathic, secondary to systemic diseases, and those caused by environmental exposures. Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias and is marked by progressive fibrosis. The secondary ILDs can be due to connective tissue diseases, drugs, or radiation therapy. Occupational and environmental ILDs are due to inhalation of harmful substances like asbestos or silica.

Clinical Features and Diagnosis

Patients typically present with progressive dyspnea and non-productive cough. Physical examination may reveal bibasilar inspiratory crackles and finger clubbing. High-resolution computed tomography (HRCT) is the imaging modality of choice, often showing reticular abnormalities, honeycombing, and ground-glass opacities. Lung biopsy may be needed in certain cases for definitive diagnosis.

Treatment and Prognosis

Treatment is largely based on the underlying cause. In IPF, antifibrotic drugs like pirfenidone and nintedanib have shown to slow disease progression. For ILDs secondary to connective tissue diseases, immunosuppressive therapy is the mainstay. Lung transplantation may be considered in advanced cases. Prognosis varies widely, with IPF having a median survival of 2-3 years from diagnosis.

Conclusion

Understanding the intricate facets of ILDs is crucial for timely diagnosis and effective management. As healthcare professionals, staying abreast of the latest advancements in this field can significantly impact patient outcomes. Future research focusing on the pathogenesis and novel therapeutic targets is the need of the hour to improve the prognosis of these debilitating disorders.